Berman Mitchell F, Solomon Robert A, Mayer Stephan A, Johnston S Claiborne, Yung Pixie P
Department of Anesthesiology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Stroke. 2003 Sep;34(9):2200-7. doi: 10.1161/01.STR.0000086528.32334.06. Epub 2003 Aug 7.
The goal of this study was to examine the impact of hospital characteristics on outcome after the treatment of ruptured and unruptured cerebral aneurysms.
We identified all discharges in New York State from 1995 through 2000 with a principal diagnosis of subarachnoid hemorrhage (SAH) or unruptured cerebral aneurysm (UCA) in patients who were treated by aneurysm clipping, wrapping, or endovascular coiling. An adverse outcome was defined as in-hospital death or discharge to a rehabilitation hospital or long-term facility. We examined the effect of hospital factors, including the rate of endovascular therapy and overall procedural volume, on outcome, length of stay, and total charges.
There were 2200 (36.9%) and 3763 (63.1%) admissions for attempted treatment of UCA and SAH, respectively. The 10 highest-volume hospitals performed half of all the procedures. Overall, hospital volume was associated with fewer adverse outcomes and lower in-hospital mortality for both UCA (adverse outcome: odds ratio [OR], 0.89; P<0.0001; mortality: OR, 0.94; P=0.002 for each 10 additional procedures performed per year) and SAH (adverse outcome: OR, 0.94; P=0.03; mortality: OR, 0.95; P=0.005). Use of endovascular therapy (each additional 10% of cases performed endovascularly) was associated with fewer adverse outcomes after treatment of unruptured aneurysm (0.83, P=0.026). Hospital volume had more of an effect on outcome after aneurysm clipping than after endovascular therapy.
Hospital procedural volume and the propensity of a hospital to use endovascular therapy are both independently associated with better outcome. Improvement in outcome could be achieved by a program of regionalization and selective referral for the treatment of cerebral aneurysms.
本研究旨在探讨医院特征对破裂和未破裂脑动脉瘤治疗后结局的影响。
我们确定了1995年至2000年纽约州所有出院病例,这些病例的主要诊断为蛛网膜下腔出血(SAH)或未破裂脑动脉瘤(UCA),且患者接受了动脉瘤夹闭、包裹或血管内栓塞治疗。不良结局定义为住院死亡或出院后入住康复医院或长期护理机构。我们研究了医院因素,包括血管内治疗率和总体手术量,对结局、住院时间和总费用的影响。
分别有2200例(36.9%)和3763例(63.1%)患者因尝试治疗UCA和SAH而入院。手术量最高的10家医院完成了所有手术的一半。总体而言,医院手术量与UCA(不良结局:比值比[OR],0.89;P<0.0001;死亡率:OR,0.94;每年每多进行10例手术,P=0.002)和SAH(不良结局:OR,0.94;P=0.03;死亡率:OR,0.95;P=0.005)的不良结局减少及住院死亡率降低相关。血管内治疗的使用(血管内治疗的病例每增加10%)与未破裂动脉瘤治疗后的不良结局减少相关(0.83,P=0.026)。医院手术量对动脉瘤夹闭术后结局的影响大于血管内治疗术后。
医院手术量和医院使用血管内治疗的倾向均与更好的结局独立相关。通过脑动脉瘤治疗的区域化和选择性转诊计划可实现结局的改善。